Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

novellia.com

Explore full profile

The era of digitomics is here

New York City, United StatesFounded 2023Health
Valuation $0–100M Latest valuation · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for novellia.com and the history behind them.

About novellia.com

Novellia, Inc. is a New York-based health technology company operating an AI-enabled platform designed to centralize and manage personal health data. The company was founded in 2023 by CEO Shashi Shankar and Chief Medical Officer Dr. Abe Abraham, both former employees of Genentech. The inspiration for the company came from Shankar's personal experience with his grandfather's late-stage cancer diagnosis, where fragmented health records hindered timely and precise care. Shankar's background is in health policy and global digital health at Roche, while Dr. Abraham has experience as a drug developer. They are joined by technical co-founder and CTO Elliot Katz, an early engineer at Zocdoc.

Read full description

The core of Novellia's business is a free-to-use personal health portal for patients in the US. This platform allows individuals to aggregate their complete medical records from tens of thousands of healthcare systems, including doctor's notes, test results, and insurance claims, into a single, secure, and continuously updated profile. The service aims to solve the problem of fragmented health data by leveraging API technology and a custom-built rules engine to normalize and de-duplicate information. Beyond record consolidation, the platform provides users with personalized educational content about their conditions and medications and matches them with suitable clinical trials.

Novellia's business model does not charge patients. Revenue is generated by licensing access to aggregated, anonymized real-world data to its primary clients: life science and biopharmaceutical companies. These clients use the rich, longitudinal datasets to gain insights into the patient journey, treatment efficacy, and care gaps, which informs research, development, and commercial strategies. This data-licensing model provides these organizations with a comprehensive view that can accelerate research and reduce costs associated with data acquisition and tokenization. The company has engaged with top global biopharma companies as customers and partners with patient advocacy groups to better understand the patient experience. In 2025, Novellia was recognized by Digital Health New York as a "Startup to Watch" and won a MedTech Breakthrough Award for "Best Electronic Health Record Service".

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
New York City, United States
Employees
38
Open positions
10
Dealroom signal
89.0/100
Industry
Health
Sector
Health, Precision Medicine, Hard Tech
Business model
SaaS
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning novellia.com.

See all news

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jun 2026 $18M $72M Spark Capital
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

novellia.com website traffic

Latest recorded traffic for novellia.com is 230K monthly website visits, up 228.6% over the last three months. novellia.com's team grew 216.7% over the past year.

Latest monthly visits230K 3-month web change+228.6% 1-year team growth+216.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Other known investors2 additional known investors

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about novellia.com on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See novellia.com’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.